Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Colombel

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Upper urinary tract tumor: conservative treatment of localized forms]Jacques Irani, Fabien Saint, Jean-Louis Bonnal, et al.
European Urology|December 28, 2010
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaHendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate]Xavier Martin, Abbou Claude, Marc Colombel, et al.
European Urology|November 26, 2013
Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trialMarc Colombel, Axel Heidenreich, Luis Martínez-Piñeiro, et al.
Journal of Robotic Surgery|April 3, 2026
Assessing the adequacy of funding for robotic-surgery hospital stays: a focused cost analysis based on 1,722 procedures in a French university hospitalArthur Lacassagne, Solène Molle, Lionel Badet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Biosensors & Bioelectronics|May 23, 2016
Corrigendum to "Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimens" [Biosens. Bioelectron. 71 (2015) 365-372]Qing Liu, Yong Shin, Jack Sheng Kee, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Biosensors & Bioelectronics|May 8, 2015
Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimensQing Liu, Yong Shin, Jack Sheng Kee, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Upper urinary tract tumor: conservative treatment of localized forms]Jacques Irani, Fabien Saint, Jean-Louis Bonnal, et al.
European Urology|December 28, 2010
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaHendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 8, 2006
[Treatment of benign prostatic hyperplasia (BPH) by transurethral needle ablation (TUNA) and 36-month follow-up of the retreatment rate]Xavier Martin, Abbou Claude, Marc Colombel, et al.
European Urology|November 26, 2013
Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trialMarc Colombel, Axel Heidenreich, Luis Martínez-Piñeiro, et al.
Journal of Robotic Surgery|April 3, 2026
Assessing the adequacy of funding for robotic-surgery hospital stays: a focused cost analysis based on 1,722 procedures in a French university hospitalArthur Lacassagne, Solène Molle, Lionel Badet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Biosensors & Bioelectronics|May 23, 2016
Corrigendum to "Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimens" [Biosens. Bioelectron. 71 (2015) 365-372]Qing Liu, Yong Shin, Jack Sheng Kee, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 25, 2007
[Urothelial tumors]Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, et al.
Biosensors & Bioelectronics|May 8, 2015
Mach-Zehnder interferometer (MZI) point-of-care system for rapid multiplexed detection of microRNAs in human urine specimensQing Liu, Yong Shin, Jack Sheng Kee, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
Pageof 12